BCPC Balchem Corporation

$154.56

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Balchem's upcoming earnings report on October 21 is poised to capture attention, particularly given the company's robust market cap of approximately $4.7 billion, which underscores its significant presence in the specialty chemicals sector. Analysts are forecasting an EPS of $1.16, with revenue expected to reach $258.28 million. However, the whisper number suggests a more optimistic EPS of $1.33, indicating that market insiders might anticipate stronger performance than the consensus. This optimism could be fueled by Balchem's strategic focus on innovation and expansion within its core markets, which has historically driven growth. As investors await the results, the key will be whether Balchem can surpass these expectations and continue its trajectory of delivering solid financial performance amidst a competitive landscape.

Updated On 12/31/2025

About Balchem Corporation

Balchem Corporation develops, manufactures, and markets specialty ingredients and performance products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. The company is headquartered in New Hampton, New York.

Website: https://www.balchem.com

Sector
LIFE SCIENCES
Industry
CHEMICALS & ALLIED PRODUCTS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
9326
Address
52 SUNRISE PARK ROAD, NEW HAMPTON, NY, US
Valuation
Market Cap
$5.25B
P/E Ratio
41.20
PEG Ratio
4.03
Price to Book
4.57
Performance
EPS
$3.92
Dividend Yield
0.54%
Profit Margin
13.50%
ROE
11.70%
Technicals
50D MA
$164.99
200D MA
$168.87
52W High
$185.06
52W Low
$136.97
Fundamentals
Shares Outstanding
33M
Target Price
$199.33
Beta
0.75

BCPC EPS Estimates vs Actual

Estimated
Actual

BCPC News & Sentiment

Dec 22, 2025 • Quiver Quantitative BULLISH
Eastman and Balchem Support EU's Anti-Dumping Duties on Choline Chloride Imports from China
Eastman and Balchem support the European Union's new anti-dumping duties of 90.0 to 115.9% on choline chloride imports from China. This measure, effective for five years, aims to protect the EU's food and feed supply chain, preserve jobs, and encourage innovation by ensuring fair trade practices. The EU industry is confident in its production capacity and commitment to health and safety standards, and will work to prevent circumvention of these new rules.
Dec 21, 2025 • Simply Wall Street BULLISH
Balchem (BCPC): Assessing Valuation After Dividend Hike and New 4 Million Share Buyback Program
Balchem (BCPC) has announced a 10.3% dividend increase and a new 4 million share buyback program, signaling a focus on shareholder returns. Despite a recent modest share price dip, the stock has shown 40% total shareholder return over five years. The company is undervalued with a fair value of $191, driven by a new microencapsulation facility and a strong clinical research pipeline.
Dec 18, 2025 • Milling Middle East & Africa BULLISH
Balchem announces new microencapsulation manufacturing facility
Balchem Corporation is investing US$25 million to build a new microencapsulation manufacturing facility in Orange County, New York. This expansion aims to meet the growing demand for encapsulated active ingredients in various food applications, reinforcing Balchem's position in clean-label and precision nutrition markets. The facility, expected to open in 2027, will significantly increase production capacity for their BakeShure®, ConfecShure®, and MeatShure® solutions, enhancing product stability, shelf life, and production efficiency for customers worldwide.
Dec 17, 2025 • Food Business News BULLISH
Balchem building new manufacturing plant
Balchem Corp. is expanding its operations by constructing a new manufacturing facility in Orange County, NY, which is expected to open in 2027. This plant will enhance the company's production capacity for microencapsulation ingredients, leveraging five decades of expertise with advanced food science and sustainable production methods. The investment aims to strengthen Balchem's US presence and support its mission to improve global health.
Dec 17, 2025 • Baking Business BULLISH
Balchem expanding through new facility
Balchem Corp. is significantly expanding its operations by building a new manufacturing facility in Orange County, NY, which is expected to open in 2027. This plant will boost the company's production capacity for its microencapsulation portfolio, including BakeShure, ConfecShure, and MeatShure, enhancing shelf life, texture, and production efficiency for confectionery, bakery, and meat products. CEO Ted Harris stated this investment strengthens Balchem's US presence and aligns with its mission to promote health.
Dec 15, 2025 • Simply Wall Street BULLISH
Why Balchem (BCPC) Is Up 5.8% After Boosting Dividend And Launching New Buyback Program
Balchem Corporation announced a 10.3% increase in its annual dividend to US$0.96 per share and authorized a new share repurchase program for up to 4,000,000 shares. These actions, alongside record quarterly sales and expansion plans, signal management's confidence in the company's growth investments and financial strength. Investors are encouraged to consider how ongoing product innovation and competitive landscape changes might affect long-term performance.
Sentiment Snapshot

Average Sentiment Score:

0.290
44 articles with scored sentiment

Overall Sentiment:

Bullish

BCPC Reported Earnings

Jul 31, 2025
Jun 30, 2025 (Pre market)
0.16 Surprise
  • Reported EPS: $1.27
  • Estimate: $1.11
  • Whisper:
  • Surprise %: 14.4%
Apr 24, 2025
Mar 31, 2025 (Pre market)
0.01 Surprise
  • Reported EPS: $1.22
  • Estimate: $1.22
  • Whisper:
  • Surprise %: 0.4%
Feb 21, 2025
Dec 31, 2024 (Pre market)
0.03 Surprise
  • Reported EPS: $1.13
  • Estimate: $1.10
  • Whisper:
  • Surprise %: 2.3%
Oct 25, 2024
Sep 30, 2024 (Pre market)
0.02 Surprise
  • Reported EPS: $1.13
  • Estimate: $1.11
  • Whisper:
  • Surprise %: 1.8%
Jul 26, 2024
Jun 30, 2024 (Pre market)
0.06 Surprise
  • Reported EPS: $1.09
  • Estimate: $1.03
  • Whisper:
  • Surprise %: 5.8%
May 03, 2024
Mar 31, 2024 (Pre market)
0.05 Surprise
  • Reported EPS: $1.03
  • Estimate: $0.98
  • Whisper:
  • Surprise %: 5.1%
Feb 16, 2024
Dec 31, 2023 (Pre market)
0.02 Surprise
  • Reported EPS: $0.95
  • Estimate: $0.93
  • Whisper:
  • Surprise %: 2.1%
Oct 27, 2023
Sep 30, 2023 (Post market)
0.07 Surprise
  • Reported EPS: $1.04
  • Estimate: $0.97
  • Whisper:
  • Surprise %: 7.2%
Jul 28, 2023
Jun 30, 2023 (Pre market)
0.22 Surprise
  • Reported EPS: $1.06
  • Estimate: $0.84
  • Whisper:
  • Surprise %: 26.2%

Financials